PhillyPharma Archive: January, 2012

Tougher federal prosecution of health-care fraud

Comment icon 0 Comments
Zane Memeger, the U.S. Attorney for the Eastern District of Pennsylvania, spoke with The Inquirer last week about his office's efforts to fight... Read more

Will AstraZeneca go shopping?

Comment icon 0 Comments
The recent drug development disappointments for AstraZeneca prompted several Wall Street analysts to tell Bloomberg News that they expect the... Read more

J&J pays $158 million to settle Texas charges on Risperdal anti-psychotic drug

Comment icon 0 Comments
Johnson & Johnson has agreed to pay $158 million to settle charges with the state of Texas over allegations that the global drug manufacturer... Read more

Big Pharma likes SOPA and PIPA

Comment icon 0 Comments
Like many in Big Media, Big Pharma has a role in the intellectual property debate, which escalated this week with Wikipedia and some other... Read more

Endo Pharmaceuticals investing in data crunching

Comment icon 0 Comments
Endo Pharmaceuticals president and chief executive officer, Dave Holveck, said that his company is spending money on data crunching. Endo's... Read more

Endo under construction

Comment icon 0 Comments
Endo Pharmaceuticals officially broke ground Tuesday afternoon on a new headquarters in Malvern. (Don't tell anyone, but the foundation is... Read more

FDA warns health care providers against short cuts on drug shortages

Comment icon 0 Comments
The U.S. Food and Drug Administration issued another warning to health care providers not to take short cuts to obtain injectable cancer drugs... Read more

Novartis to cut 1,960 jobs in U.S.

Comment icon 0 Comments
Novartis said early Friday morning that it would cut 1,960 jobs in the United States within the next few months to deal with the impending... Read more